<?xml version="1.0" encoding="UTF-8"?>
<p>An oral influenza antiviral (oseltamivir) improved pulmonary function and reduced exacerbation frequency in one randomized, placebo-controlled trial in school-age asthmatic children who had influenza (
 <xref ref-type="bibr" rid="CR18">18</xref>). Unfortunately, increasing resistance of the influenza virus to antiviral agents limits their use as a long-term strategy to reduce illness in asthmatic children. The concept of using antivirals to reduce asthma morbidity in children seems theoretically promising.
</p>
